Skip to main content

Advertisement

Table 1 Clinical characteristics and expression of CLASP2 and EMT markers mRNA

From: CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor

Variables Patients (n) Progression within 2 years  
No (n) Yes (n) P
Total (%) 102 68 34  
Gender
 Male 72 52 20 0.11
 Female 30 16 14
Age(years)
  < 60 38 27 11 0.61
  > 60 64 41 23
Intravesical instillation
 Immediate 29 22 7 0.31
 Maintenance 73 46 27
Tumor stage
 Ta 34 25 9 0.41
 T1 68 43 25
Tumor grade
 G1 33 26 7 0.04
 G2 49 33 16
 G3 20 9 11
Concomitant CIS
 Yes 3 1 2 0.26
 No 99 67 32
Tumor size (cm)
  < 3 59 44 15 0.07
  > 3 43 24 19
Multiplicity
 Single 44 34 10 0.06
 Multiple 58 34 24
CLASP2 mRNA (tumor)
 High 30 6 24 <0.01
 Low 72 62 10
CLASP2 mRNA (urine)
 High 55 24 31 < 0.01
 Low 47 44 3
E-cadherin mRNA (tumor)
 High 62 52 10 < 0.01
 Low 40 16 24
E-cadherin mRNA (urine)
 High 60 54 6 < 0.01
 Low 42 14 28
Vimentin mRNA (tumor)
 High 55 31 24 0.16
 Low 47 37 10
Vimentin mRNA (urine)
 High 62 36 26 0.03
 Low 40 32 8